First Time Loading...

Clovis Oncology Inc
NASDAQ:CLVS

Watchlist Manager
Clovis Oncology Inc Logo
Clovis Oncology Inc
NASDAQ:CLVS
Watchlist
Price: 0.093 USD 3.33% Market Closed
Updated: May 18, 2024

Clovis Oncology Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clovis Oncology Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Clovis Oncology Inc
NASDAQ:CLVS
EPS (Diluted)
-$2
CAGR 3-Years
31%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$3
CAGR 3-Years
6%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
18%
CAGR 5-Years
-39%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$7
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$15
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$33
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Clovis Oncology Inc's EPS (Diluted)?
EPS (Diluted)
-2.3 USD

Based on the financial report for Dec 31, 2021, Clovis Oncology Inc's EPS (Diluted) amounts to -2.3 USD.

What is Clovis Oncology Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
24%

Over the last year, the EPS (Diluted) growth was 48%. The average annual EPS (Diluted) growth rates for Clovis Oncology Inc have been 31% over the past three years , 24% over the past five years .